Former ResMed CFO Brett Sandercock joins 4DMedical Board
Filed with ASX · · 2 pages · English
Summary by 6ix AI
4DMedical Ltd. announces the appointment of Brett Sandercock as an independent Non-Executive Director, effective immediately. Brett Sandercock, former CFO of ResMed, will chair the Audit and Risk Committee and join the Remuneration and Nomination Committee. His extensive experience in finance leadership within global healthcare technology is expected to enhance the Board's capabilities. The Board considers him an independent director and he will stand for election at the next Annual General Meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from 4DMedical
- Application for quotation of securities - 4DX
- Becoming a substantial holder
- Response to ASX Price Query
- Pause in Trading
- Final Director's Interest Notice -LB
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical